Recent Press Releases

Stryker's Performance Solutions Announces JointCOACH

Engagement Platform Designed to Educate and Navigate Patients Through the Entire Episode of Joint Replacement Care Provides patients with 90-days of education and high touchpoint engagement from...

Philips Volcano announces more than 5,000 Coronary Artery Disease patients enrolled in iFR Outcomes Trials

1-year results of instant wave-Free Ratio (iFR®) modality clinical outcomes trials expected in 2017 Amsterdam, the Netherlands and San Diego, CA, US – Royal Philips (NYSE: PHG; AEX: PHIA)...

Veracyte Secures Up to $45 Million in Financing from Visium Healthcare Partners

Veracyte Secures Up to $45 Million in Financing from Visium Healthcare Partners SOUTH SAN FRANCISCO, Calif. and NEW YORK, March 28, 2016 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT), a molecular...

Quanterix Raises $46 Million in Series D Financing

Quanterix Raises $46 Million in Series D Financing The company's post-money valuation exceeds $200 million; Capital being used to accelerate global expansion of Quanterix' proprietary platform into...

Award of Funding for Next Stage of US Department of Defense Programme to Develop Genedrive® Biohazard Identification Tests

RNS Press Release For release: 21 March 2016 Award of Funding for Next Stage of US Department of Defense Programme to Develop Genedrive® Biohazard Identification Tests Epistem Holdings Plc (LSE:...

The Myriad myRisk Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer

The Myriad myRisk Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer New Data Presented at the Society for Gynecologic Oncology Annual Meeting...

MDxHealth Launches SelectMDx "Liquid Biopsy" Test in the United States

MDxHealth Launches SelectMDx "Liquid Biopsy" Test in the United States Non-invasive, urine-based prostate cancer assay available as a laboratory developed test IRVINE, CA, and HERSTAL, BELGIUM...

10x Genomics Completes $55 Million Series C Financing

10x Genomics Completes $55 Million Series C Financing Financing led by Fidelity; 10x to accelerate commercialization efforts PLEASANTON, CA—MARCH 17, 2016—10x Genomics, a company focused...

Intuitive Surgical Announces U.S. Clearance for da Vinci Xi Single-Site Instruments and Accessories

Leading second generation robotic technology enables surgeons to operate through single incision, resulting in virtually scarless surgery SUNNYVALE, Calif., March 16, 2016 (GLOBE NEWSWIRE) --...

Silk Road Medical Announces CE Mark Approval and First Patients Treated with the Next Generation ENROUTE® Transcarotid Neuroprotection System

System Designed Specifically for Novel TransCarotid Artery Revascularization (TCAR) Procedure Intended to Prevent Stroke in Patients with Carotid Artery Disease SUNNYVALE, Calif., March 15, 2016...

Foundation Medicine Presents New Data at the 2016 USCAP Annual Meeting Underscoring Importance of Comprehensive Genomic Profiling in Cancer Care

Foundation Medicine Presents New Data at the 2016 USCAP Annual Meeting Underscoring Importance of Comprehensive Genomic Profiling in Cancer Care Latest Data Demonstrate the Clinical Utility of...

Guardant Health and COTA Partner to Explore the Costs, Benefits, and Barriers of Genotyping Patients with Advanced Lung Cancer with a Non-invasive Liquid Biopsy

Guardant Health and COTA Partner to Explore the Costs, Benefits, and Barriers of Genotyping Patients with Advanced Lung Cancer with a Non-invasive Liquid Biopsy NEW YORK, March 15, 2016 (GLOBE...

Sight Sciences Announces the Closing of its $7MM Series B Financing Led by Hicks Equity Partners

MENLO PARK, Calif., March 15, 2016 /PRNewswire/ -- Sight Sciences, Inc., a venture-backed, commercial stage ophthalmic medical device company today announced it has closed a $7 million Series B round...

Baxter Enrolls First Patient in U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System

DEERFIELD, Ill., March 15, 2016 — Baxter International Inc. (NYSE:BAX) today announced enrollment of the first patient in a U.S. clinical trial for VIVIA, an investigational home hemodialysis...

Fighting infections with viruses

Scientists at the University of Brighton have shown that viruses can kill bacteria and may be used to combat common infections related to the use of medical devices such as catheters. 9 February 2016...

Helomics® Launches GeneFx® Colon to Identify Patients with High Risk Stage II Colon Cancer

Helomics® Launches GeneFx® Colon to Identify Patients with High Risk Stage II Colon Cancer Proprietary microarray-based gene signature marker identifies patients' recurrence risk within five...

Serenium Announces a Groundbreaking Biomarker Development Program with a Global Strategic Partner to Accelerate Early Identification of People at Risk for Chronic Disease

Serenium Announces a Groundbreaking Biomarker Development Program with a Global Strategic Partner to Accelerate Early Identification of People at Risk for Chronic Disease Serenium's first-ever...

Dexcom G5® Mobile Continuous Glucose Monitoring System Now Available on the Apple Watch

Glucose Data and Trends Viewable on Apple Watch and with New Today View Widget SAN DIEGO, March 14, 2016 /PRNewswire/ -- Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM)...

GE Selects Chicago for Deep Investments in Digital -- Creating 160 New Jobs

GE Selects Chicago for Deep Investments in Digital -- Creating 160 New Jobs - Hiring 160 new digital jobs in Chicago area -- majority in the city; total GE presence 2,000 strong in greater Chicago -...

New Study Shows that Genetic Information from Prostate Needle Biopsy May Be Used to Predict Tumor Aggressiveness

New Study Shows that Genetic Information from Prostate Needle Biopsy May Be Used to Predict Tumor Aggressiveness Study published in Journal of Molecular Diagnostics shows concordance in molecular...